ALIUXTA

Serial Number 99027910
661

Registration Progress

Application Filed
Feb 4, 2025
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

ALIUXTA

Basic Information

Serial Number
99027910
Filing Date
February 4, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
661
Status Date
Jun 17, 2025
Application
Pending
Classes
005

Rights Holder

Glaxo Group Limited

99
Address
GSK Medicines Research Centre
Gunnels Wood Road
Stevenage SG1 2NY
GB

Ownership History

Glaxo Group Limited

Original Applicant
99
Stevenage GB

Legal Representation

Attorney
Elizabeth K. Rucki

USPTO Deadlines

All Deadlines Cleared

All 3 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

10 events
Date Code Type Description Documents
Jun 17, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 17, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 17, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 13, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 13, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 13, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Mar 8, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 4, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 4, 2025 NWAP I NEW APPLICATION ENTERED Loading...
Feb 4, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiopulmonary, genitourinary, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases; Vaccines; excluding vaccines for the treatment of cancer and cardiovascular disorders; Anti-infectives

Classification

International Classes
005